Sep 21, 2024
The Memo: AccuLine Preventing the Next Heart Attack
Sep 14, 2024
The Memo: VESTECK Revolutionizing Endovascular Aortic Repair
Sep 7, 2024
The Memo: ArthroSave Revolutionizing Joint-Preserving Treatment of End-Stage Knee Osteoarthritis
Aug 31, 2024
The Memo: Terapet Leading a New Era in Proton Therapy
Aug 24, 2024
The Memo: Askel Healthcare Redefines Cartilage Repair
Aug 17, 2024
The Memo: THERYQ’s Bold Step Forward in Cancer Treatment
Aug 11, 2024
The Memo: Aortyx Leading a New Era in Aortic Disease Management
Aug 3, 2024
The Memo: How Atraverse Medical is Revolutionizing Left-Heart Access and Streamlining Procedures
Jul 28, 2024
The Memo: How FeelTect is Revolutionizing Compression Therapy for Venous Leg Ulcers
Jul 20, 2024
The Memo: How Vitestro’s Automating Blood Draw With Robotics
Jul 14, 2024
The Memo: Interventional Systems is Bridging the Gap in Surgical Robotics
Jun 30, 2024
Unlocking the Mysteries of the Brain: How Neuroelectrics is Pioneering a New Era of Brain Health
The Memo is your go-to source for in-depth insights into the world of emerging medtech companies. Each edition features members of the LSI Alumni community, offering a comprehensive look at their journey. We dive into their origin story, explore the current landscape for their innovative technologies, and highlight the cutting-edge solutions they’re developing to address critical healthcare challenges.
Through exclusive interviews and market data from our Medtech Market Intelligence Platform, we provide valuable context on market trends, growth opportunities, and competitive positioning. The Memo also covers key progress and milestones these companies achieve along the way, from clinical trials to regulatory approvals and market launches.
Stay ahead of the curve with The Memo—where we shine a light on the emerging medtech companies shaping the future of healthcare.
Work with us
Accelerate your business
We’re here to help you make smarter decisions and form stronger
partnerships through curated events, independent market intelligence
products and services, and digital-forward media.